A BILL 
To amend title III of the Public Health Service Act to 
terminate the effective time period for immunity for 
manufacturers of COVID–19 vaccines, and for other pur-
poses. 
Be it enacted by the Senate and House of Representa-
1
tives of the United States of America in Congress assembled, 
2
SECTION 1. LIABILITY OF COVID–19 VACCINE MANUFAC-
3
TURERS. 
4
Notwithstanding any other provision of law, in apply-
5
ing section XII of the ‘‘Declaration Under the Public 
6
Readiness and Emergency Preparedness Act for Medical 
7
Countermeasures Against COVID–19’’ issued pursuant to 
8
23:17 Dec 09, 2021
H6106
2 
•HR 6106 IH
section 319F–3(b)(2)(B) of the Public Health Service Act 
1
(42 U.S.C. 247d–6d(b)(2)(B)), with respect to manufac-
2
turers of COVID–19 vaccines, the reference to October 1, 
3
2024, shall be deemed a reference to December 1, 2021. 
4
Æ 
23:17 Dec 09, 2021
H6106
